1. Home
  2. CUZ vs VKTX Comparison

CUZ vs VKTX Comparison

Compare CUZ & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cousins Properties Incorporated

CUZ

Cousins Properties Incorporated

HOLD

Current Price

$22.60

Market Cap

3.9B

Sector

Real Estate

ML Signal

HOLD

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$33.66

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUZ
VKTX
Founded
1958
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.7B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
CUZ
VKTX
Price
$22.60
$33.66
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$28.33
$88.00
AVG Volume (30 Days)
1.6M
2.3M
Earning Date
04-29-2026
04-22-2026
Dividend Yield
5.76%
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$993,816,000.00
N/A
Revenue This Year
$4.19
N/A
Revenue Next Year
$3.89
N/A
P/E Ratio
$92.48
N/A
Revenue Growth
16.00
N/A
52 Week Low
$21.03
$20.41
52 Week High
$30.80
$43.15

Technical Indicators

Market Signals
Indicator
CUZ
VKTX
Relative Strength Index (RSI) 47.89 51.62
Support Level $21.11 $33.65
Resistance Level $23.33 $36.23
Average True Range (ATR) 0.73 1.92
MACD 0.11 0.01
Stochastic Oscillator 58.52 70.55

Price Performance

Historical Comparison
CUZ
VKTX

About CUZ Cousins Properties Incorporated

Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: